TUMEFACTIVE MULTIPLE SCLEROSIS

This adverse event was reported 170 times

These drugs are most commonly taken by patients reporting TUMEFACTIVE MULTIPLE SCLEROSIS:

# Drug Count
0 FINGOLIMOD HCL 99
1 FINGOLIMOD HYDROCHLORIDE 34
2 FINGOLIMOD 32
3 PREDNISOLONE 12
4 PREDNISOLONE ORAL 12
5 PREDNISOLONE ORAL SOLUTION 12
6 ADALIMUMAB-AATY 10
7 LEFLUNOMIDE 10
8 METHOTREXATE 10
9 METHOTREXATE SODIUM 10
See all common drugs associated with TUMEFACTIVE MULTIPLE SCLEROSIS

TUMEFACTIVE MULTIPLE SCLEROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FINGOLIMOD HYDROCHLORIDE 34 0.0067
1 FINGOLIMOD HCL 99 0.0011
2 PREDNISOLONE SODIUM PHOSPHATE 1 0.0004
3 ALEMTUZUMAB 5 0.0003
4 UBLITUXIMAB 1 0.0003
5 AMANTADINE HYDROCHLORIDE 1 0.0002
6 ADALIMUMAB-AATY 10 0.0002
7 ADALIMUMAB-FKJP 9 0.0002
8 OFATUMUMAB 6 0.0002
9 ADALIMUMAB-ADAZ 9 0.0002
See all drugs enriched for association with TUMEFACTIVE MULTIPLE SCLEROSIS